Psychology & Psychiatry

Adjunct minocycline no benefit for treatment-resistant depression

For patients with treatment-resistant depression (TRD), minocycline as add-on to antidepressant treatment as usual does not reduce depressive symptoms, according to a study published online Sept. 14 in JAMA Network Open.

Psychology & Psychiatry

Teens and depression—a back-to-school concern

With many teens heading back to school, peer pressure and academic expectations are once again a reality. These added pressures can cause ups and downs during what can be an already tumultuous time of life. For some teens, ...

Psychology & Psychiatry

Research finds biomarkers in older adults with late-life depression

Major depression in older adults is very common, disabling, and increases the risk of many diseases of aging, including Alzheimer's disease and other dementias, cardiovascular issues and even mortality. Therefore, it constitutes ...

Genetics

Genetic testing may benefit patients with depression

A new U.S. Department of Veterans Affairs study found that pharmacogenomic testing can help providers avoid prescribing antidepressant medications that may have undesirable outcomes. Pharmacogenomics is the study of how genes ...

Medications

Why ketamine is a speedster antidepressant

Ketamine is the speedster of antidepressants, working within hours compared to more common antidepressants that can take several weeks. But ketamine can only be given for a limited amount of time because of its many side ...

page 4 from 40